The purpose of this study is to compare the efficacy of Kovacaine Mist, and Placebo for inducing pulpal anesthesia of the maxillary teeth in pediatric patients.
The study will employ a multi-center, randomized, double-blind, placebo-controlled, parallel-groups design to demonstrate the safety and efficacy of Kovacaine Mist delivered intranasally for inducing pulpal anesthesia of maxillary permanent teeth numbers 4 to 13 (maxillary right second premolar to maxillary left second premolar) or maxillary primary teeth numbers A to J (maxillary right second primary molar to maxillary left second primary molar) sufficient to allow completion of the Study Dental Procedure. The maxillary teeth will be categorized in two subsets, anterior teeth (permanent teeth numbers 6 to 11 and primary teeth numbers C to H) and posterior teeth (permanent teeth numbers 4, 5, 12, 13 and primary teeth numbers A, B, I, J). The intent is to treat 90 male and female subjects aged 3 to 17 years, inclusive, at 3 study sites, 2:1 randomization within each study site, and an overall goal of 60 subjects treated with Kovacaine Mist and 30 treated with placebo. Subjects will receive Kovacaine Mist or placebo (2:1) according to the kit randomization plan within three dosing strata (100 µL, 200 µL or 400 µL) based on subject weight at entry: subjects weighing 10 to \<20 kg, 20 to \<40 kg and ≥ 40 kg will be assigned to the 100 µL, 200 µL or 400 µL dose group, respectively. Recruitment will be from diverse pediatric dental patient populations. To ensure adequate representation in the 3 dose/weight groups, each stratum will contain at least 25% of subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
90
Intranasally administered regional anesthetic
Inactive ingredients supplied in identical nasal sprayer
Center for Dental Research Loma Linda University School
Loma Linda, California, United States
Big Grins
Fort Collins, Colorado, United States
Number of Participants Who Completed the Study Dental Procedure Without Need for Rescue by Injection of Local Anesthetic.
If the participant does not have sufficient anesthesia to complete the Study Dental Procedure, the participant is given a rescue injection of local anesthetic and is considered a failure for this outcome.
Time frame: 100µL dose - at 10 minutes, +3 minute window; for subjects who receive the 200µL or 400µL dose - at 15 minutes, +3 minute window
Number of Participants Who Completed the Study Dental Procedure Without Need for Rescue by Injection of Local Anesthetic.by Dosage Cohort.
If the participant does not have sufficient anesthesia to complete the Study Dental Procedure, the participant is given a rescue injection of local anesthetic and is considered a failure for this outcome.
Time frame: 100µL dose - at 10 minutes, +3 minute window; for subjects who receive the 200µL or 400µL dose - at 15 minutes, +3 minute window
Number of Participants Who Completed the Study Dental Procedure Without Need for Rescue by Injection of Local Anesthetic. by Age Group (3-5, 6-11, and 12-17 Years Old, Inclusive).
If the participant does not have sufficient anesthesia to complete the Study Dental Procedure, the participant is given a rescue injection of local anesthetic and is considered a failure for this outcome.
Time frame: 100µL dose - at 10 minutes, +3 minute window; for subjects who receive the 200µL or 400µL dose - at 15 minutes, +3 minute window
Incidence of Adverse Events (AEs) by Dosage Cohort
Patients with AEs
Time frame: from baseline to 24 hours following drug administration
Incidence of Adverse Events (AEs) by Age Group
Patients with AEs
Time frame: from baseline to 24 hours following drug administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Results of Naris Examination (NE) - Patency and Ulcerations
The investigators evaluated the treatment naris for patency and ulcerations. Patency was evaluated as followed: The nostril not used for dosing study drug was manually occluded and the subject was asked to sniff gently. Airflow in the naris was used to determine if it was patent (yes) or not (no). For ulcers, the investigators performed a visual examination for the presence of ulcers and recorded if they were present (yes) or not (no).
Time frame: 120 minutes post drug administration
Maximum Change From Baseline in Heart Rate
Time frame: from baseline to 24 hours following drug administration
Maximum Change From Baseline in Systolic Blood Pressure
Time frame: from baseline to 24 hours following drug administration
Maximum Change From Baseline in Diastolic Blood Pressure
Time frame: from baseline to 24 hours following drug administration
Results of Naris Examination (NE) - Color
The investigators performed a visual inspection and evaluated the treatment naris for color of the mucosa. The investigator determined what color (Pink, Slightly Red, Red) best matched and recorded the results.
Time frame: 120 minutes post drug administration
Results of Naris Examination (NE) - Inflammation
Time frame: 120 minutes post drug administration
Results of Naris Examination (NE) - Bleeding
Time frame: 120 minutes post drug administration